Hikma raises generics unit forecast on strong doxycycline sales

08-11-2013 ReutersComments (0)

DoxycyclineGenericsHikma Pharmaceuticals

Hikma Pharmaceuticals Plc said it expects full-year revenue growth of 20 percent and raised its sales forecast for its generics unit as sales of antibiotic doxycycline continued to soar. The drugmaker now expects full-year sales in ...

Read more on Reuters

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top